Great week for Bristol-Myers Squibb Company (NYSE:BMY) institutional investors after losing 0.8% over the previous year

Every investor in Bristol-Myers Squibb Company (NYSE:BMY) should be aware of the most powerful shareholder groups. The group holding the most number of shares in the company, around 80% to be precise, ...

FDA Approves Bristol-Myers Squibb’s Breyanzi as First-Ever CAR T Therapy for Rare Marginal Zone Lymphoma

Bristol-Myers Squibb Company (NYSE: BMY) is one of the best stocks to buy for the next 5 years. On December 15, Goldman Sachs ...
Nasdaq

The Zacks Analyst Blog Highlights Bristol-Myers Squibb, Medtronic, Altria Group, Target and FedEx

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features a real-time update on the Q1 earnings season, in addition to new research reports on 16 ...
ETF Daily News

Jefferies Financial Group Cuts Bristol-Myers Squibb (NYSE:BMY) Price Target to $68.00

Bristol-Myers Squibb (NYSE:BMY – Free Report) had its target price reduced by Jefferies Financial Group from $70.00 to $68.00 in a research report sent to investors on Wednesday morning,Benzinga ...